Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial

BONE MARROW TRANSPLANTATION

卷 52, 期 8, 页码 1194-1198

NATURE PUBLISHING GROUP

-

Biophysics Oncology Hematology Immunology Transplantation

1. Celgene
2. The Binding Site
3. Dutch Cancer Foundation
4. German Federal Ministry of Education and Research
5. Janssen-Cilag
6. Novartis
7. Amgen
8. Chugai
9. Roche
10. Tumorzentrum Heidelberg/Mannheim
11. Janssen-Cilag, Neuss Germany
12. Dietmar Hopp Stiftung, Walldorf Germany